ARTICLE | Clinical News
Oxycodone/naltrexone: Pilot trial data
March 3, 2014 8:00 AM UTC
An open-label, cross-over pilot trial in 16 healthy volunteers showed that all 3 doses of twice-daily ELI-201 were bioequivalent to an undisclosed reference drug based on pharmacokinetic measures, inc...